Key points are not available for this paper at this time.
This Viewpoint discusses ways in which payer license agreements can facilitate widespread lenacapavir use, a key step in ending the HIV epidemic.
Share your take
Add a clinician perspective alongside expert commentary.
Rose et al. (Wed,) studied this question.